Christopher J. Schultz

14.3k total citations · 4 hit papers
138 papers, 8.7k citations indexed

About

Christopher J. Schultz is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Radiation. According to data from OpenAlex, Christopher J. Schultz has authored 138 papers receiving a total of 8.7k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Pulmonary and Respiratory Medicine, 43 papers in Genetics and 39 papers in Radiation. Recurrent topics in Christopher J. Schultz's work include Glioma Diagnosis and Treatment (43 papers), Advanced Radiotherapy Techniques (39 papers) and Head and Neck Cancer Studies (35 papers). Christopher J. Schultz is often cited by papers focused on Glioma Diagnosis and Treatment (43 papers), Advanced Radiotherapy Techniques (39 papers) and Head and Neck Cancer Studies (35 papers). Christopher J. Schultz collaborates with scholars based in United States, Canada and China. Christopher J. Schultz's co-authors include Bruce H. Campbell, Minesh P. Mehta, Mitchell Machtay, Jay S. Cooper, Anthony J. Cmelak, Arlene A. Forastiere, Julie A. Kish, Harold E. Kim, Thomas F. Pajak and Scott Saxman and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and Blood.

In The Last Decade

Christopher J. Schultz

130 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck

2004 2.3k citations Jay S. Cooper, Thomas F. Pajak et al. New England Journal of Medicine profile →
Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial

2013 742 citations Mark R. Gilbert, Meihua Wang et al. Journal of Clinical Oncology profile →
Combination Chemotherapy and Radiotherapy for Primary Central Nervous System Lymphoma: Radiation Therapy Oncology Group Study 93-10

2002 522 citations Wendy Seiferheld, Christopher J. Schultz et al. Journal of Clinical Oncology profile →
Long-term Follow-up of the RTOG 9501/Intergroup Phase III Trial: Postoperative Concurrent Radiation Therapy and Chemotherapy in High-Risk Squamous Cell Carcinoma of the Head and Neck

2012 385 citations Jay S. Cooper, Thomas F. Pajak et al. International Journal of Radiation Oncology*Biology*Physics profile →

Peers

Countries citing papers authored by Christopher J. Schultz

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Schultz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Schultz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Schultz more than expected).

Fields of papers citing papers by Christopher J. Schultz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Schultz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Schultz. The network helps show where Christopher J. Schultz may publish in the future.

Co-authorship network of co-authors of Christopher J. Schultz

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Schultz. A scholar is included among the top collaborators of Christopher J. Schultz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Schultz. Christopher J. Schultz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comprehensive Molecular Analysis in NRG Oncology/RTOG 9813: A Phase 3 Study of Radiation and Temozolomide Versus Radiation and BCNU/CCNU in Anaplastic Astrocytoma 2025 ·International Journal of Radiation OncologyBiologyPhysics ·Jessica L. Fleming, Stephanie L. Pugh, Susan M. Chang, Joseph P. McElroy, Aline Paixão Becker, Kenneth Aldape, Helen A. Shih, Lynn S. Ashby, G.K. Hunter, Jean-Paul Bahary, Christopher J. Schultz, Brian D. Kavanagh, Vinay K. Puduvalli, H. Ian Robins, Maria Werner‐Wasik, Minesh P. Mehta, Arnab Chakravarti	1
2	Enhanced IoT Water Quality Monitoring System for Data-Based Aquaculture 2024 ·Christopher J. Schultz, Michael Smith	1
3	Changes in Daily Apparent Diffusion Coefficient on Fully Quantitative Magnetic Resonance Imaging Correlate With Established Genomic Pathways of Radiation Sensitivity and Reveal Novel Biologic Associations 2024 ·International Journal of Radiation OncologyBiologyPhysics ·William A. Hall, Angela Mathison, (unknown), Michael Tschannen, (unknown), Michael Straza, Musaddiq Awan, Lindsay Puckett, C.A. Lawton, Christopher J. Schultz, Raúl Urrutia, Sarah L. Kerns, Javier F. Torres–Roca, X. Allen Li, Bradley A. Erickson, Marja T. Nevalainen, Michael T. Zimmermann, E.S. Paulson	0
4	Evolution in the Presence and Evidence Category of Radiation Therapy Treatment Recommendations in the National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology 2023 ·Advances in Radiation Oncology ·(unknown), Javier Mora, Michael Straza, Bradley A. Erickson, C.A. Lawton, Christopher J. Schultz, Adam Currey, Meena Bedi, Malika Siker, William A. Hall	2
5	Obtaining organ-specific radiobiological parameters from clinical data for radiation therapy planning of head and neck cancers 2023 ·Physics in Medicine and Biology ·(unknown), X. Allen Li, (unknown), Musaddiq Awan, Christopher J. Schultz, A. Tai	4
6	4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience 2020 ·Clinical and Translational Radiation Oncology ·E.S. Paulson, E Ahunbay, Xinfeng Chen, Nikolai J. Mickevicius, Guang‐Pei Chen, Christopher J. Schultz, Bradley A. Erickson, Michael Straza, William A. Hall, X. Allen Li	92
7	Lymph node yield, depth of invasion, and survival in node-negative oral cavity cancer 2019 ·Oral Oncology ·(unknown), Vasu Divi, (unknown), Becky Massey, Bruce H. Campbell, Monica Shukla, Musaddiq Awan, Christopher J. Schultz, Aditya Shreenivas, Stuart J. Wong, Ryan S. Jackson, (unknown)	27
8	NRG oncology RTOG 9006: a phase III randomized trial of hyperfractionated radiotherapy (RT) and BCNU versus standard RT and BCNU for malignant glioma patients 2018 ·Journal of Neuro-Oncology ·Arif N. Ali, Peixin Zhang, W.K. Alfred Yung, Yuhchyau Chen, Benjamin Movsas, Raul C. Urtasun, Christopher U. Jones, Kwang Nam Choi, Jeff M. Michalski, Andreas Fischbach, Arnold M. Markoe, Christopher J. Schultz, Marta Peñas-Prado, Madhur Garg, Alan C. Hartford, Harold E. Kim, Minhee Won, Walter J. Curran	25
9	Consolidative Whole-Brain Radiation Therapy Versus Autologous Stem Cell Transplant for Primary Central Nervous System Lymphoma: A Large Dose of Perspective and Perhaps a Lower Dose of Radiation Are in Order 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Joseph Bovi, Christopher J. Schultz, Minesh P. Mehta, Benjamin W. Corn	1
10	Progressing Bevacizumab-Induced Diffusion Restriction Is Associated with Coagulative Necrosis Surrounded by Viable Tumor and Decreased Overall Survival in Patients with Recurrent Glioblastoma 2016 ·American Journal of Neuroradiology ·Ha Son Nguyen, (unknown), (unknown), Elizabeth J. Cochran, Jennifer Connelly, Joseph Bovi, Christopher J. Schultz, Wade M. Mueller, Scott D. Rand, Kathleen M. Schmainda, Peter S. LaViolette	56
11	Use of Helical TomoTherapy for the Focal Hypofractionated Treatment of Limited Brain Metastases in the Initial and Recurrent Setting 2015 ·Frontiers in Oncology ·(unknown), (unknown), Joseph Bovi, Christopher J. Schultz	5
12	Dose-Dense Temozolomide for Newly Diagnosed Glioblastoma: A Randomized Phase III Clinical Trial breakdown → 2013 ·Journal of Clinical Oncology ·Mark R. Gilbert, Meihua Wang, Kenneth Aldape, Roger Stupp, Monika E. Hegi, Kurt A. Jaeckle, Terri S. Armstrong, Jeffrey S. Wefel, Minhee Won, Deborah T. Blumenthal, Anita Mahajan, Christopher J. Schultz, Sara Erridge, Brigitta G. Baumert, (unknown), Tzahala Tzuk-Shina, Paul D. Brown, Arnab Chakravarti, Walter J. Curran, Minesh P. Mehta	742
13	Early Postoperative Paclitaxel Followed by Concurrent Paclitaxel and Cisplatin With Radiation Therapy for Patients With Resected High-Risk Head and Neck Squamous Cell Carcinoma: Report of the Phase II Trial RTOG 0024 2009 ·Journal of Clinical Oncology ·David I. Rosenthal, Jonathan Harris, Arlene A. Forastiere, Randal S. Weber, John A. Ridge, Jeffrey N. Myers, Adam S. Garden, Michael Kuettel, (unknown), Christopher J. Schultz, Andy Trotti, K. Kian Ang	32
14	Role of Radiation Therapy in Cutaneous Melanoma 2009 ·Clinics in Plastic Surgery ·(unknown), Malika Siker, Mackenzie Daly, Christopher J. Schultz	6
15	Clinical Outcomes of Patients Receiving Integrated PET/CT-Guided Radiotherapy for Head and Neck Carcinoma 2008 ·International Journal of Radiation OncologyBiologyPhysics ·(unknown), Mohit Maheshwari, Christopher J. Schultz, Michelle A. Michel, Stuart J. Wong, Bruce H. Campbell, Becky Massey, J. Frank Wilson, Dian Wang	71
16	Phase II Radiation Therapy Oncology Group trial of conventional radiation therapy followed by treatment with recombinant interferon-β for supratentorial glioblastoma: Results of RTOG 9710 2006 ·International Journal of Radiation OncologyBiologyPhysics ·Howard Colman, Brian Berkey, Moshe Maor, Morris D. Groves, Christopher J. Schultz, Sandra Vermeulen, Diana F. Nelson, Minesh P. Mehta, W.K. Alfred Yung	45
17	Phase 2 trial of radiation plus high-dose tamoxifen for glioblastoma multiforme: RTOG protocol BR-00211 2006 ·Neuro-Oncology ·H. Ian Robins, Minhee Won, Wendy Seiferheld, Christopher J. Schultz, Ali Choucair, David Brachman, William F. Demas, Minesh P. Mehta	48
18	Early postoperative paclitaxel followed by paclitaxel and cisplatin concurrent with radiation therapy (RT) (phase II trial RTOG H-0024) is well tolerated for patients with resected, high-risk squamous carcinoma of the head and neck (HNSCC) 2004 ·International Journal of Radiation OncologyBiologyPhysics ·David I. Rosenthal, Jay R. Harris, Arlene A. Forastiere, Randal S. Weber, John A. Ridge, Jeffrey N. Myers, Adam S. Garden, Michael Kuettel, (unknown), Christopher J. Schultz, K. Kian Ang	2
19	Postoperative Concurrent Radiotherapy and Chemotherapy for High-Risk Squamous-Cell Carcinoma of the Head and Neck breakdown → 2004 ·New England Journal of Medicine ·Jay S. Cooper, Thomas F. Pajak, Arlene A. Forastiere, Joseph B. Jacobs, Bruce H. Campbell, Scott Saxman, Julie A. Kish, Harold E. Kim, Anthony J. Cmelak, Marvin Rotman, Mitchell Machtay, John F. Ensley, K. S. Clifford Chao, Christopher J. Schultz, Nancy Y. Lee, Karen K. Fu	2295
20	Planned postradiotherapy neck dissection in patients with advanced head and neck cancer 1998 ·Head & Neck ·(unknown), Paul M. Harari, Scott P. Tannehill, Marta Voytovich, Gregory K. Hartig, Charles N. Ford, Robert L. Foote, Bruce H. Campbell, Christopher J. Schultz	85

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact